Category: Oral HypoglycemicActive constituent: GlimepirideConcentrations: 4 mg Indications: Type II Diabetes mellitusDose : Once dailyThe effective sulphonylurea with the safest hypoglycemic potentialPromising enhancement in insulin resistance.
UPC
56 th queen farida st., al miraj city
New maadi
Cairo
Egypt
Phone: +202 26 17 61 85
Fax: +20224470563
Email: upc@egyupc.com
UPC is an Egyptian company operating in the pharmaceutical field since 1998 Dr.Yehia Saudi is the company CEO.